Skip to main content

Table 2 Suitability of re-randomization in the setting of (1) in vitro fertilization, (2) severe asthma exacerbations, and (3) acute sickle cell pain crises

From: Using re-randomization to increase the recruitment rate in clinical trials – an assessment of three clinical areas

Clinical area

Setting requirement

Justification

In vitro fertilization

1) Some patients may require treatment on multiple occasions

Some participants who do not become pregnant after their first IVF cycle may undergo further cycles

2) The intervention(s) would be used for each new treatment episode

The interventions considered (minimal stimulation, sperm selection) are designed to be used for each new cycle

3) The intervention duration and length of the follow-up period for each treatment episode are less than the overall length of the trial recruitment period

The interventions considered (minimal stimulation, sperm selection) are short-term (during the IVF cycle)

The follow-up period will vary between trials, but will often be complete once it is determined a cycle was unsuccessful

Severe asthma exacerbations

1) Some patients may require treatment on multiple occasions

Some patients may experience more than one exacerbation during a given time period

2) The intervention(s) would be used for each new treatment episode

The interventions considered (magnesium sulphate) are designed to be used for each new exacerbation

3) The intervention duration and length of the follow-up period for each treatment episode are less than the overall length of the trial recruitment period

The interventions considered (magnesium sulphate) is short-term, and given while a patient is experiencing an exacerbation.

The follow-up period will vary between trials, but is often relatively short-term

Acute sickle cell pain crises

1) Some patients may require treatment on multiple occasions

Some patients may experience more than one pain crisis during a given time period

2) The intervention(s) would be used for each new treatment episode

The interventions considered (nitric oxide gas, ketoprofen) are designed to be used for each new pain crisis

3) The intervention duration and length of the follow-up period for each treatment episode are less than the overall length of the trial recruitment period

The interventions considered (nitric oxide gas, ketoprofen) is short-term, and given while a patient is experiencing a pain crisis.

The follow-up period will vary between trials, but is often relatively short-term